findmyKOL
Clinical trialNCT07308938Not, yet, recruitingPhase 2Interventional

Fluorometholone Study

SponsorVishal JhanjiEnrollment174Corneal Ulcer (Diagnosis)Keratitis Bacterial
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The investigators seek to determine whether adjunctive topical fluorometholone (FML) improves best-corrected visual acuity (BCVA) at 3 months in patients with bacterial corneal ulcers compared with standard topical antibiotic therapy alone.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Upmc Vision Institute

    Pittsburgh, Pennsylvania, United States

    Alex Mammen, MDPrakash Gaurav, MDSabrina Mukhtar, MDVishal Jhanji, MD

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Adjunctive Topical Fluorometholone 0.1%Standard Topical Antibiotic Therapy
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2026
Primary completion
31 Dec 2029
Completion
31 Dec 2030
Last update posted
10 Jun 2026
Registered enrollment
174
Registry id
NCT07308938

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.